CEO Corner

51. Leading And Managing Change During A Time Of Transition And Cultural Transformation 7/1/2020

    While strategic leadership during times of transition and transformation can be especially challenging, consistently prioritizing organizational goals and strategies is paramount to success.

52. Leading With Authenticity In Turbulent Times 6/1/2020

    Today, as we strive to be adaptive and productive during the pandemic, leaders can play an important role in “normalizing” the unthinkable and leading with authenticity and truth has never been more important.

53. Becoming The CEO 5/1/2020

    Two years ago, I was destined for retirement. Now, I’m the CEO of a company that is developing an ultra-long-lasting dosage form that will allow people to take their medicine once a week or even once a month.

54. Insights From A First-Time Biotech CEO 4/1/2020

    Alessandro Riva, M.D. is a first-time biotech CEO who shares some of the values and leadership strategies he has learned over the years, including how to foster a culture of relentless innovation.

55. Effective Patient Engagement Starts With Strong Relationships 2/28/2020

    If patients are always at the heart of why we do what we do, then why do they feel that pharmaceutical companies don’t truly understand their needs?

56. From Consumer Products CEO To Biopharma CEO 10/1/2019

    Walter Klemp, CEO of Moleculin, shares several lessons he learned from his consumer-product background.

57. My Advice To Aspiring Biopharma Entrepreneurs 8/30/2019

    When it comes to achieving success, a few commonalities have crystallized for me during my 30+ years in the pharma industry. Here I share five key tenets that I have found critical to success over the arc of my career.

58. Do You Know The 4 Pillars To Drive Stakeholder Value? 7/1/2019

    Thirty-year pharma veteran Nancy Lurker shares her four pillars on which to build your business and why they are crucial to driving stakeholder value over the mid- to long-term.

59. The Forgotten Piece Of The Opioid Epidemic — And How It Can Be Addressed 5/31/2019

    To address the opioid epidemic we need an all-out national prevention effort akin to the one that finally began to slow the AIDS epidemic in the 1990s. Here are four actions that could help “unlock” the problem.

60. From Academia To Pharma CEO: Challenges And Lessons Learned 5/1/2019

    “Looking back on my 25 years in academic medical research, I can’t think of a single learning experience that equipped me for the world of entrepreneurship, running a public company, or interacting with the capital markets.”